Carlyle Group on Friday divested nearly a 2 per cent stake in private sector lender Yes Bank for Rs 1,441 crore through an open market transaction.
US-based Carlyle Group, through its affiliate CA Basque Investments, offloaded shares in Yes Bank through a bulk deal on the National Stock Exchange (NSE).
As per the data, CA Basque Investments sold 59.40 crore shares, amounting to a 1.98 per cent stake in Yes Bank.
The shares were disposed of at an average price of Rs 24.27 apiece, taking the transaction value to Rs 1,441.64 crore.
After the stake sale, the Carlyle Group’s shareholding in Yes Bank has declined to 7.13 per cent from 9.11 per cent.
In February this year, global investment firm Carlyle Group pared a 1.3 per cent stake in private sector lender Yes Bank for Rs 1,057 crore.
Meanwhile, Goldman Sachs (Singapore) Pte – ODI bought more than 36.92 crore shares, representing a 1.23 per cent stake in the Mumbai-based lender.
The shares were acquired at an average price of Rs 24
Posts in category Business Standard
Carlyle Group divests 2% stake in YES Bank for Rs 1,441 cr via open market (03-05-2024)
Board of Raymond approves acquisition of Ray Global Consumer Enterprise (03-05-2024)
At meeting held on 03 May 2024
TVS Holdings announces acquisition of balance stake in Emerald Haven Towers (03-05-2024)
Powered by Capital Market – Live News
Prospect Commodities inks multi-year deal with Africa Negoce Industries (03-05-2024)
Prospect Commodities has signed a MOU with Africa Negoce Industries (ANI). The total trade value of this MOU exceeds $4 million and is set to span until March 25, aiming to fortify the supply chain of raw cashew nuts and cashew husk/pellet.
Board of Aptus Value Housing Finance India approves NCD issuance up to Rs 2,250 cr (03-05-2024)
At meeting held on 03 May 2024
USFDA completes inspection of Eugia Pharma Specialities’ Unit II (03-05-2024)
The inspection closed with 7 observations. The observations are procedural in nature and will be responded to within the stipulated time.
USFDA completes inspection of Eugia Pharma Specialities’ Unit II (03-05-2024)
The inspection closed with 7 observations. The observations are procedural in nature and will be responded to within the stipulated time.
Sebi gives approval to CARE Ratings’ subsidiary to provide ESG ratings (03-05-2024)
Capital markets regulator Sebi has given approval to CARE Ratings Ltd’s subsidiary CARE ESG Ratings to provide environmental, social, and governance (ESG) ratings.
Such ratings will enable the issuers to discern steps for the betterment of their sustainability performance.
Having received the registration under the Sebi (Credit Rating Agencies) Regulations on May 2, 2024, CARE ESG Ratings Ltd will commence its ESG rating activity, according to a statement issued by CareEdge Group on Friday.
“With the use of ESG ratings, a sustainable growth journey of businesses can get an independent viewpoint. A business can now assess its relative position and take action to strengthen its sustainability policies & practices.
Investors and stakeholders have adopted new perspectives on ESG-based reporting, and performance, both domestically and internationally,” Mehul Pandya, MD and Group CEO of CareEdge, said.
Last month, Sebi gave clearance to ICRA’s subsidiary Pragati Development Consulting .
Kriti Nutrients standalone net profit rises 55.42% in the March 2024 quarter (03-05-2024)
Sales decline 4.92% to Rs 172.27 crore